A new blood marker reflects the extent of brain injury after an ischemic stroke and can predict patient outcomes months to ...
Strokes are a medical emergency, yet imaging can capture only snapshots of how brain damage develops in the hours and days ...
TAMPA, Fla. — Tampa Bay’s main airport has a new leader. Tampa International Airport’s new CEO, Michael Stephens, has been on the job for about five weeks now after being selected for the position ...
Introduction: Alteplase is known to increase the risk of blood-brain barrier integrity disruption, potentiating hemorrhage and edema. Evolving edema reduces chances of good functional outcomes. There ...
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...
ABSTRACT: Objective: Analyzing the differences in clinical efficacy and safety of intravenous thrombolysis with alteplase in patients with acute ischemic stroke across different age groups. Methods: A ...
Objectives: To investigate the real-world usage patterns and clinical outcomes of low-dose (0.6 mg/kg) versus standard-dose (0.9 mg/kg) intravenous alteplase in patients with acute ischemic stroke ...
In a significant move for stroke treatment, researchers at the University of Cincinnati have found that a commonly used clot-busting drug, alteplase, could be effective even when administered up to 24 ...
Intravenous alteplase is beneficial for patients who present with an acute ischemic stroke and salvageable brain tissue on imaging—with or without a large-vessel occlusion (LVO)—up to 24 hours after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback